Trending Stocks Today: NANO Nuclear Energy Inches up 8.83% Post-Market

June 28th - US stocks trending post-market.Gainers: $NANO Nuclear Energy(NNE.US)$ climbs 8.83% to $25.51 with a turnover of $5.29 million. $Ginkgo Bioworks(DNA.US)$ up 3.2% to $0.35 with a turnover of

Moomoo NewsJun 28 16:30 ET

Sector Update: Health Care Stocks Steady Premarket Friday

Health care stocks were steady premarket Friday with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) inactive recently. Sarepta Therapeutics (SRPT) rallie

MT NewswiresJun 21 09:12 ET

Ocugen's Receives Nod to Enrol in High Dose Study of Stargardt Disease Drug Candidate

Ocugen (OCGN) said Friday that the Data and Safety Monitoring Board approved proceeding with the high dose of its experimental drug OCU410ST to treat Stargardt disease, a rare eye disease, in the dose

MT NewswiresJun 21 08:04 ET

Express News | Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease

ReutersJun 21 07:00 ET

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

• Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial• DSMB Determination to Proceed with High Dose Cohort DosingMALVERN, Pa., June 21, 2024 (GLOBE NEWSWIRE) -- O

OcugenJun 21 00:00 ET

Express News | Ocugen Shares Are Trading Lower. The Company Announced That the First Patient Has Been Dosed in Its Phase 3 LiMeliGhT Clinical Trial for OCU400—a Modifier Gene Therapy Product Candidate Being Developed for Retinitis Pigmentosa

BenzingaJun 20 11:25 ET